TDOC
Teladoc Health, Inc.
NYSE · Healthcare · Medical - Healthcare Information Services · US
$6.28
−2.94%Year over year
Reported trailing growth
- Revenue
- -2.1%
- EBITDA
- —
- EBIT
- +35.1%
- EPS
- +17.5%
- Free cash flow
- +7.1%
- Operating cash flow
- -13.9%
Forward estimates
Based on analyst estimates
- Revenue
- -4.5%
- EBITDA
- -51.5%
- EPS
- +26.6%
Three-year CAGR
- Revenue
- +1.7%
- EBITDA
- +83.8%
- EBIT
- +74.2%
- Net income
- +80.0%
- EPS
- +80.6%
- Free cash flow
- +18.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026